Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype

被引:52
|
作者
Riveiro-Barciela, M. [1 ,2 ,3 ]
Bes, M. [3 ,4 ]
Rodriguez-Frias, F. [2 ,3 ,5 ,6 ]
Tabernero, D. [2 ,3 ,5 ,6 ]
Ruiz, A. [2 ,3 ,5 ,6 ]
Casillas, R. [7 ]
Vidal-Gonzalez, J. [1 ,2 ]
Homs, M. [2 ,3 ,5 ,6 ]
Nieto, L. [2 ,5 ,6 ]
Sauleda, S. [3 ,4 ]
Esteban, R. [1 ,2 ,3 ]
Buti, M. [1 ,2 ,3 ]
机构
[1] Hosp Univ Vall dHebron, Dept Internal Med, Liver Unit, Barcelona, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedade Hepat & Digest, Madrid, Spain
[4] Serv Catala Salut, Banc Sang & Teixits, Transfus Safety Lab, Barcelona, Spain
[5] Hosp Univ Vall dHebron, Dept Biochem, Liver Pathol Unit, Barcelona, Spain
[6] Hosp Univ Vall dHebron, Dept Microbiol, Virol Unit, Barcelona, Spain
[7] Vall dHebron Inst Recerca, Barcelona, Spain
关键词
HBcrAg; HBeAg negative chronic hepatitis B; HBsAg; HBV inactive carrier; Hepatitis B; Hepatitis B virus genotype; NATURAL-HISTORY; GENETIC-VARIABILITY; VIRAL LOAD; INFECTION; PERSPECTIVE; SEROCLEARANCE; MARKERS; LEVEL; DNA;
D O I
10.1016/j.cmi.2017.03.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate whether hepatitis B surface antigen (HBsAg) and hepatitis B core-related antigen (HBcrAg) levels are useful to identify inactive carriers among HBeAg-negative patients infected by different hepatitis B virus (HBV) genotypes. Methods: In all, 202 consecutive HBeAg-negative patients with chronic hepatitis B, 135 inactive carriers and 67 with HBV activity, were prospectively followed for 1 year. Results: In HBeAg-negative patients, HBsAg levels differed across the different genotypes (p < 0.001). The highest levels were observed in genotypes F or H (4.2 +/- 0.6 logIU/mL), followed by genotype E (3.4 +/- 1.1 logIU/mL), genotype A (3.4 +/- 0.8 logIU/mL), and the lowest in genotype D (2.7 +/- 1.1 logIU/mL). Variations in HBsAg levels were similar in inactive carriers and patients with HBV activity. HBsAg < 3 logIU/mL showed good performance for identifying genotype D inactive carriers: 76% of genotype D inactive carriers met this cut-off versus <= 31% for genotypes A, E, F or H. However, in patients with genotype A, HBsAg levels <= 3.7 logIU/mL better classified inactive carriers. The combination of a single measurement of HBcrAg <= 3 logU/mL plus HBV DNA <= 2000 IU/mL yielded a positive predictive value and diagnostic accuracy > 85% in all HBV genotypes, except genotype H or F, with values of 62.5% and 72.7%, respectively, for the two parameters. Conclusions: HBsAg levels varied across genotypes in HBeAg-negative patients. HBsAg levels < 3 logIU/mL were only useful for identifying genotype D inactive carriers. A single HBcrAg measurement <= 3 logU/mL plus HBV DNA <= 2000 IU/mL was highly accurate for identifying inactive carriers, regardless of their HBV genotype. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:860 / 867
页数:8
相关论文
共 50 条
  • [31] Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B
    Loggi, Elisabetta
    Vukotic, Ranka
    Conti, Fabio
    Grandini, Elena
    Gitto, Stefano
    Cursaro, Carmela
    Galli, Silvia
    Furlini, Giuliano
    Re, Maria Carla
    Andreone, Pietro
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) : 568 - 575
  • [32] Kinetics of Hepatitis B Core-Related Antigen and Anti-Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus-Hepatitis B Coinfection
    Dezanet, Lorenza N. C.
    Maylin, Sarah
    Gabassi, Audrey
    Rougier, Hayette
    Miailhes, Patrick
    Lascoux-Combe, Caroline
    Chas, Julie
    Girard, Pierre-Marie
    Delaugerre, Constance
    Lacombe, Karine
    Boyd, Anders
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (11) : 1826 - 1837
  • [33] Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (06) : 717 - 726
  • [34] Spontaneous Flares of Chronic Hepatitis B Virus in Hepatitis Be Antigen Negative Carriers Who Subsequently Clear Hepatitis B Surface Antigen
    Iluz-Freundlich, Daniel
    Samad, Nabeel
    Miles, David
    Osiowy, Carla
    Kaita, Kelly
    Wong, Stephen
    Cuvelier, Susan
    Peretz, David
    Uhanova, Julia
    Minuk, Gerald Y.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 257 - 262
  • [35] Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
    Caviglia, Gian Paolo
    Armandi, Angelo
    Rosso, Chiara
    Ribaldone, Davide Giuseppe
    Pellicano, Rinaldo
    Fagoonee, Sharmila
    DIAGNOSTICS, 2021, 11 (02)
  • [36] Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
    Maasoumy, B.
    Wiegand, S. B.
    Jaroszewicz, J.
    Bremer, B.
    Lehmann, P.
    Deterding, K.
    Taranta, A.
    Manns, M. P.
    Wedemeyer, H.
    Glebe, D.
    Cornberg, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (06) : 606.e1 - 606.e10
  • [37] Hepatitis B Core-Related Antigen: From Virology to Clinical Application
    Lee, Hye Won
    Ahn, Sang Hoon
    Chan, Henry Lik-Yuen
    SEMINARS IN LIVER DISEASE, 2021, 41 (02) : 182 - 190
  • [38] Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
    Mak, Lung-Yi
    Ko, Kwan-Lung
    To, Wai-Pan
    Wong, Danny Ka-Ho
    Seto, Wai-Kay
    Fung, James
    Yuen, Man-Fung
    GUT AND LIVER, 2020, 14 (05) : 665 - 668
  • [39] Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
    Yim, Sun Young
    Kim, Tae Hyung
    Jun, Suh Sang
    Kim, Eun Sun
    Keum, Bora
    Seo, Yeon Seok
    Yim, Hyung Joon
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Lee, Hong Sik
    Um, Soon Ho
    Kim, Chang Duck
    Won, Nam Hee
    Ryu, Ho Sang
    GUT AND LIVER, 2017, 11 (03) : 417 - 425
  • [40] Hepatitis B Core-related Antigen: An Alternative to Hepatitis B Virus DNA to Assess Treatment Eligibility in Africa
    Shimakawa, Yusuke
    Ndow, Gibril
    Njie, Ramou
    Njai, Harr Freeya
    Takahashi, Kazuaki
    Akbar, Sheikh Mohammad Fazle
    Cohen, Damien
    Nayagam, Shevanthi
    Jeng, Adam
    Ceesay, Arnie
    Sanneh, Bakary
    Baldeh, Ignatius
    Imaizumi, Masayasu
    Moriyama, Kazushige
    Aoyagi, Katsumi
    D'Alessandro, Umberto
    Mishiro, Shunji
    Chemin, Isabelle
    Mendy, Maimuna
    Thursz, Mark R.
    Lemoine, Maud
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1442 - 1452